Literature DB >> 34661156

Machine Learning of Bone Marrow Histopathology Identifies Genetic and Clinical Determinants in Patients with MDS.

Oscar E Brück1,2,3,4, Susanna E Lallukka-Brück1, Helena R Hohtari1,2, Aleksandr Ianevski5, Freja T Ebeling4, Panu E Kovanen6, Soili I Kytölä7, Tero A Aittokallio3,5,8, Pedro M Ramos9, Kimmo V Porkka1,2,3,4, Satu M Mustjoki1,2,3,10.   

Abstract

In myelodysplastic syndrome (MDS) and myeloproliferative neoplasm (MPN), bone marrow (BM) histopathology is assessed to identify dysplastic cellular morphology, cellularity, and blast excess. Yet, other morphologic findings may elude the human eye. We used convolutional neural networks to extract morphologic features from 236 MDS, 87 MDS/MPN, and 11 control BM biopsies. These features predicted genetic and cytogenetic aberrations, prognosis, age, and gender in multivariate regression models. Highest prediction accuracy was found for TET2 [area under the receiver operating curve (AUROC) = 0.94] and spliceosome mutations (0.89) and chromosome 7 monosomy (0.89). Mutation prediction probability correlated with variant allele frequency and number of affected genes per pathway, demonstrating the algorithms' ability to identify relevant morphologic patterns. By converting regression models to texture and cellular composition, we reproduced the classical del(5q) MDS morphology consisting of hypolobulated megakaryocytes. In summary, this study highlights the potential of linking deep BM histopathology with genetics and clinical variables. SIGNIFICANCE: Histopathology is elementary in the diagnostics of patients with MDS, but its high-dimensional data are underused. By elucidating the association of morphologic features with clinical variables and molecular genetics, this study highlights the vast potential of convolutional neural networks in understanding MDS pathology and how genetics is reflected in BM morphology. See related commentary by Elemento, p. 195. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2021        PMID: 34661156      PMCID: PMC8513905          DOI: 10.1158/2643-3230.BCD-20-0162

Source DB:  PubMed          Journal:  Blood Cancer Discov        ISSN: 2643-3230


  29 in total

Review 1.  Deep learning.

Authors:  Yann LeCun; Yoshua Bengio; Geoffrey Hinton
Journal:  Nature       Date:  2015-05-28       Impact factor: 49.962

2.  Opening the black box of machine learning.

Authors: 
Journal:  Lancet Respir Med       Date:  2018-10-18       Impact factor: 30.700

3.  Bone remodeling alterations in myelodysplastic syndrome.

Authors:  L Mellibovsky; A Diez; S Serrano; J Aubia; E Pérez-Vila; M L Mariñoso; X Nogués; R R Recker
Journal:  Bone       Date:  1996-10       Impact factor: 4.398

4.  Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis.

Authors:  Jacob H Levine; Erin F Simonds; Sean C Bendall; Kara L Davis; El-ad D Amir; Michelle D Tadmor; Oren Litvin; Harris G Fienberg; Astraea Jager; Eli R Zunder; Rachel Finck; Amanda L Gedman; Ina Radtke; James R Downing; Dana Pe'er; Garry P Nolan
Journal:  Cell       Date:  2015-06-18       Impact factor: 41.582

5.  Dermatologist-level classification of skin cancer with deep neural networks.

Authors:  Andre Esteva; Brett Kuprel; Roberto A Novoa; Justin Ko; Susan M Swetter; Helen M Blau; Sebastian Thrun
Journal:  Nature       Date:  2017-01-25       Impact factor: 49.962

Review 6.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

7.  Pan-cancer image-based detection of clinically actionable genetic alterations.

Authors:  Alexander T Pearson; Tom Luedde; Jakob Nikolas Kather; Lara R Heij; Heike I Grabsch; Chiara Loeffler; Amelie Echle; Hannah Sophie Muti; Jeremias Krause; Jan M Niehues; Kai A J Sommer; Peter Bankhead; Loes F S Kooreman; Jefree J Schulte; Nicole A Cipriani; Roman D Buelow; Peter Boor; Nadi-Na Ortiz-Brüchle; Andrew M Hanby; Valerie Speirs; Sara Kochanny; Akash Patnaik; Andrew Srisuwananukorn; Hermann Brenner; Michael Hoffmeister; Piet A van den Brandt; Dirk Jäger; Christian Trautwein
Journal:  Nat Cancer       Date:  2020-07-27

8.  QuPath: Open source software for digital pathology image analysis.

Authors:  Peter Bankhead; Maurice B Loughrey; José A Fernández; Yvonne Dombrowski; Darragh G McArt; Philip D Dunne; Stephen McQuaid; Ronan T Gray; Liam J Murray; Helen G Coleman; Jacqueline A James; Manuel Salto-Tellez; Peter W Hamilton
Journal:  Sci Rep       Date:  2017-12-04       Impact factor: 4.379

9.  Deep learning based tissue analysis predicts outcome in colorectal cancer.

Authors:  Dmitrii Bychkov; Nina Linder; Riku Turkki; Stig Nordling; Panu E Kovanen; Clare Verrill; Margarita Walliander; Mikael Lundin; Caj Haglund; Johan Lundin
Journal:  Sci Rep       Date:  2018-02-21       Impact factor: 4.379

10.  Machine learning demonstrates that somatic mutations imprint invariant morphologic features in myelodysplastic syndromes.

Authors:  Yasunobu Nagata; Ran Zhao; Hassan Awada; Cassandra M Kerr; Inom Mirzaev; Sunisa Kongkiatkamon; Aziz Nazha; Hideki Makishima; Tomas Radivoyevitch; Jacob G Scott; Mikkael A Sekeres; Brian P Hobbs; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2020-11-12       Impact factor: 25.476

View more
  3 in total

1.  Machine learning identifies the independent role of dysplasia in the prediction of response to chemotherapy in AML.

Authors:  Raphael Itzykson; Thomas Cluzeau; Matthieu Duchmann; Orianne Wagner-Ballon; Thomas Boyer; Meyling Cheok; Elise Fournier; Estelle Guerin; Laurène Fenwarth; Bouchra Badaoui; Nicolas Freynet; Emmanuel Benayoun; Daniel Lusina; Isabel Garcia; Claude Gardin; Pierre Fenaux; Cécile Pautas; Bruno Quesnel; Pascal Turlure; Christine Terré; Xavier Thomas; Juliette Lambert; Aline Renneville; Claude Preudhomme; Hervé Dombret
Journal:  Leukemia       Date:  2021-10-06       Impact factor: 11.528

2.  A Novel Prognostic Scoring Model for Myelodysplastic Syndrome Patients With SF3B1 Mutation.

Authors:  Liya Ma; Bin Liang; Huixian Hu; Wenli Yang; Shengyun Lin; Lihong Cao; Kongfei Li; Yuemin Kuang; Lihong Shou; Weimei Jin; Jianping Lan; Xingnong Ye; Jing Le; Huyi Lei; Jiaping Fu; Ying Lin; Wenhua Jiang; Zhiying Zheng; Songfu Jiang; Lijuan Fu; Chuanyong Su; XiuFeng Yin; Lixia Liu; Jiayue Qin; Jie Jin; Shenxian Qian; Guifang Ouyang; Hongyan Tong
Journal:  Front Oncol       Date:  2022-06-27       Impact factor: 5.738

Review 3.  Personalized Risk Schemes and Machine Learning to Empower Genomic Prognostication Models in Myelodysplastic Syndromes.

Authors:  Hussein Awada; Carmelo Gurnari; Arda Durmaz; Hassan Awada; Simona Pagliuca; Valeria Visconte
Journal:  Int J Mol Sci       Date:  2022-03-03       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.